OOIR: Observatory of International Research

Papers

(The H4-Index of Drug Delivery is 45. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Oral delivery of the intracellular domain of the insulinoma-associated protein 2 (IA-2ic) by bacterium-like particles (BLPs) prevents type 1 diabetes mellitus in NOD mice	224
The development and evaluation of hyaluronic acid coated mitochondrial targeting liposomes for celastrol delivery	219
Development of microparticles for oral administration of Periplaneta americana extract to treat ulcerative colitis	202
Alginate-based aerogels as wound dressings for efficient bacterial capture and enhanced antibacterial photodynamic therapy	174
Rapid oral transmucosal delivery of zaleplon–lavender oil utilizing self-nanoemulsifying lyophilized tablets technology: development, optimization and pharmacokinetic evaluation	171
Hyaluronic acid-based nanoparticles to deliver drugs to the ocular posterior segment	157
Acoustic triggered nanobomb for US imaging guided sonodynamic therapy and activating antitumor immunity	150
Immunomodulatory nano-preparations for rheumatoid arthritis	145
Advanced hydrogel material for colorectal cancer treatment	103
Exploring the effects of cannabidiol encapsulation in liposomes on their physicochemical properties and biocompatibility	85
Oral liposomal delivery of an activatable budesonide prodrug reduces colitis in experimental mice	85
Transdermal delivery of colchicine using dissolvable microneedle arrays for the treatment of acute gout in a rat model	80
Recent progress in nanotechnology-based drug carriers for resveratrol delivery	78
Functional ligands for improving anticancer drug therapy: current status and applications to drug delivery systems	75
Co-delivery of amphotericin B and pentamidine loaded niosomal gel for the treatment of Cutaneous leishmaniasis	74
Electroporation induced changes in extracellular vesicle profile	69
Luteolin-loaded exosomes derived from bone marrow mesenchymal stem cells: a promising therapy for liver fibrosis	68
Correction	67
Effect of pH-sensitive nanoparticles on inhibiting oral biofilms	66
Formulation of novel niosomal repaglinide chewable tablets using coprocessed excipients: in vitro characterization, optimization and enhanced hypoglycemic activity in rats	65
Surface functionalized nanomaterial systems for targeted therapy of endocrine related tumors: a review of recent advancements	64
Pitavastatin-loaded bilosomes for oral treatment of hepatocellular carcinoma: a repurposing approach	64
The role of lipid particle-laden interfaces in regulating the co-delivery of two hydrophobic actives from o/w emulsions	61
The discovery of berberine erythrocyte-hemoglobin self-assembly delivery system: a neglected carrier underlying its pharmacokinetics	57
Thermo-sensitive self-assembly of poly(ethylene imine)/(phenylthio) acetic acid ion pair in surfactant solutions	57

Development of a single-dose Q fever vaccine with an injectable nanoparticle-loaded hydrogel: effect of sustained co-delivery of antigen and adjuvant	57
Effect and mechanism of paclitaxel loaded on magnetic Fe ₃ O ₄ @mSiO ₂ -NH ₂	57
Quantitative analysis of therapeutic proteins in biological fluids: recent advancement in analytical techniques	56
Cannabidiol lymphatic transport after oral administration assessed using a novel thoracic lymph duct cannulated conscious pig model	56
Exploring the efficacy and constraints of platinum nanoparticles as adjuvant therapy in silicosis management	55
Recent trends in platelet membrane-cloaked nanoparticles for application of inflammatory diseases	55
Advance in placenta drug delivery: concern for placenta-originated disease therapy	55
Enhancement of the oral bioavailability of isopropoxy benzene guanidine though complexation with hydroxypropyl-β-cyclodextrin	54
Development, optimization, and evaluation of a nanostructured lipid carrier of sesame oil loaded with miconazole for the treatment of oral candidiasis	51
Nanoparticles-based anti-aging treatment of Alzheimer’s disease	51
Boosting the anti MERS-CoV activity and oral bioavailability of resveratrol via PEG-stabilized emulsomal nano-carrier: Factorial design, in-vitro and in-vivo assessments	51
Orally administered intelligent self-ablating nanoparticles: a new approach to improve drug cellular uptake and intestinal absorption	49
Optimization of mirtazapine loaded into mesoporous silica nanostructures via Box-Behnken design: in-vitro characterization and in-vivo assessment	48
Platinum-based drugs and hydrogel: a promising anti-tumor combination	48
Disordered mesoporous silica particles: an emerging platform to deliver proteins to the lungs	48
PEGylated Tween 80-functionalized chitosan-lipidic nano-vesicular hybrids for heightening nose-to-brain delivery and bioavailability of metoclopramide	48
SREKA-targeted liposomes for highly metastatic breast cancer therapy	48
Tumor microenvironment-responsive conformational activation of apoA-I mimetic peptides for targeted cancer therapy	46
Application of chitosan-based drug delivery systems in the treatment of bacterial diseases: a review	46
Nanotransethosomes for enhanced transdermal delivery of mangiferin against rheumatoid arthritis: formulation, characterization, invivo pharmacokinetic and pharmacodynamic evaluation	46
Multifunctional icariin and tanshinone IIA co-delivery liposomes with potential application for Alzheimer’s disease	45
Targeting interleukin-13 receptor α2 (IL-13Rα2) for glioblastoma therapy with surface functionalized nanocarriers	45
PEGylation technology: addressing concerns, moving forward	45